Indore (Pithampur) manufacturer of pharmaceutical bulk drugs and excipients — ferrous sulphate, MCCP, cellulose powder, diclofenac sodium and other allied APIs.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -1 | -0 | 1 | 1 | 2 | 3 | 5 | 5 |
| Borrowings | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3 |
| Other Liabilities | 26 | 17 | 1 | 14 | 28 | 32 | 34 | 18 |
| Total Liabilities | 42 | 33 | 19 | 31 | 47 | 51 | 55 | 43 |
| AssetsFixed Assets | 10 | 10 | 9 | 9 | 9 | 8 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 32 | 23 | 9 | 22 | 38 | 43 | 48 | 36 |
| Total Assets | 42 | 33 | 19 | 31 | 47 | 51 | 55 | 43 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 1 | 1 | 1 | -0 | -0 | 2 | -2 | -1 |
| Cash from Investing | -1 | -0 | -0 | -0 | -0 | -0 | -0 | 1 |
| Cash from Financing | -0 | -1 | -1 | -0 | 0 | -0 | 0 | 3 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -0 | 1 | 1 | -0 | -0 | 2 | -2 | 1 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
BIOFILCHEM · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.